Navigation Links
Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
Date:11/27/2007

D at GSK. "We are extremely pleased to see the continued rapid and impressive achievements of the team driving this successful collaboration."

"Since entering into this collaboration just over 18 months ago, we have advanced multiple programs focusing on compelling targets toward development candidates," said David Floyd, Ph.D., Executive Vice President and Chief Scientific Officer of Pharmacopeia "We are very pleased that progress within the collaboration exceeds our initial estimates and that compounds are coming from multiple programs in multiple therapeutic areas. We're particularly happy to have added a second lead to our ongoing pain program as this significantly increases its chances of overall success."

About The CEEDD

GlaxoSmithKline is enhancing the way it discovers and develops drugs by creating a small dedicated team who will feed the GSK pipeline solely through the efforts of its external alliances. The CEEDD (Center of Excellence for External Drug Discovery) was formed as further validation of GSK's strategy to create small, independent and accountable R&D teams (Centers of Excellence for Drug Discovery or CEDDs). In essence, the CEEDD will 'virtualize' a portion of the GSK pipeline; namely, from Target to Clinical Proof of Concept, by forming multiple risk-sharing/reward-sharing alliances. Capitalizing on the speed and efficiency of its collaborators will allow GSK to deliver pharmaceuticals products faster to patients.

ABOUT PHARMACOPEIA

Pharmacopeia is a clinical development stage biopharmaceutical company dedicated to discovering and developing novel small molecule therapeutics to address significant medical needs. The company has a broad portfolio of clinical and preclinical candidates under development internally or by partners including seven clinical compounds in Phase 2 or Phase 1 development addressing multiple indications including hypertension, diabetic nephropathy, muscle wasting, inflammation and respira
'/>"/>

SOURCE Pharmacopeia
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Pharmacopeia Announces Senior Additions to Management Team
2. Pharmacopeia Acquires Selective Androgen Receptor Modulator (SARM) Program from Bristol-Myers Squibb
3. GlaxoSmithKline Responds to JAMA Articles
4. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
5. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
6. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
7. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
8. GlaxoSmithKline Aids California Fire Relief Efforts
9. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
10. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
11. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... RI (PRWEB) May 22, 2013 Hurricane ... weatherproofing your home. That’s why Amica Insurance ... coverages for the upcoming hurricane season. , “An important ... said Bryan Cook, a senior assistant vice president at ... needs is before the threat of a storm.” , ...
(Date:5/22/2013)... HR Strategies recently participated in the Gwinnett ... Fairgrounds, on Friday May 10, 2013. For never having ... raising over $6,300 for cancer research. , HR ... the first $3,000 for Bronze Level Sponsorship. HR Strategies ... to match the company’s contribution of $3,000; and after ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Homeopathic Vibes is ... cannot make it to the store during normal hours. On ... “The change is to accommodate some of our patients who ... the day time or on Saturdays,” says owner and homeopathic ... 10 a.m. to 6 p.m. Monday through Friday; weekends are ...
(Date:5/22/2013)... Fish oil supplements could help reduce the risk ... The supplements, also known as omega-3 fatty ... that,s linked to insulin sensitivity, Harvard researchers found. ... have also been linked to a lower risk ... found fish oil increased circulating adiponectin, whether similar ...
(Date:5/22/2013)... depression have on his young son or daughter? When fathers ... their children benefit, said a University of Illinois study. , ... to be able to attend to the child,s emotional state, ... notice whether he is getting frustrated or needs help. Depressed ... U of I professor of human development. , But if ...
Breaking Medicine News(10 mins):Health News:Reviewing Insurance Policies: a Key Part of Hurricane Preparations 2Health News:HR Strategies Raises Over $6,300 for Cancer Research via Relay For Life 2Health News:Homeopathic Vibes Now Open Late on Wednesdays 2Health News:Fish Oil Pills Might Cut Diabetes Risk, Researchers Say 2Health News:Good marriage can buffer effects of dad's depression on young children 2
... Recent study reports that women don’t have to worry about their ... fertility is higher only in their thirties. // Women don’t have ... be a constraint for conception of babies. Researchers have found from ... as man as increased considerably. The fertility rate of women in ...
... as formed a new cabinet committee to plan strategies to ... has said that though the United Kingdom //Government has taken ... flu spread but the committee feels still a lot has ... ,The committee feels that the Government should organize the food ...
... Motion has been developed by University of Toronto scientists with ... again. The device makes the muscles// work again by sending ... called functional electrical stimulation or FES, is unlike similar therapies ... is not dependent on the machine. ,Instead, the ...
... it takes to get pregnant or conceive the sex of the ... by Dutch reserachers. //The sample size was 5,283 women who gave ... ,Among the 498 women who took longer than 12 months ... whereas the proportion of male births among the 4,785 women with ...
... UK Parliamentarian Roger Williams has called for a ban ... the production of 6,000 types of medicines, food and ... the sweetener, which is used in cereal, chocolate and ... published reports that aspartame caused cancer in rats. Doses ...
... the Government in treating drug addicts is beginning to yield ... users seeking treatment in 2004. Heroin users accounted for 8,000 ... the number of people trying to get back to normal ... the figures, which also said that the percentage of heroin ...
Cached Medicine News:
(Date:5/22/2013)... , May 22, 2013  For the 3% of ... sweating is often embarrassing, uncomfortable, anxiety-inducing and disabling.  While ... or treated for their symptoms, hyperhidrosis is a serious ... solution available called Precision TX™. Dr. ... Skin & Laser Center in New York ...
(Date:5/22/2013)... , May 22, 2013  Modern Medical announced ... (ODM).  Launched in November 2012 in a test ... program to stop the rising opioid abuse in ... customized program designed to protect employees, physicians and ... the necessary balance to provide pain relief for ...
(Date:5/22/2013)... STEPh, Inc., a full service medical communications ... web site ( http://www.stephreports.com ) dedicated to ... STEPh Reports STEPh Reports are comprehensive critical ... STEPh Report assesses the competitive landscape by individual drug ... and specific key issues.  STEPh Reports are written by ...
Breaking Medicine Technology:Is There Finally A Way To Stop Severe Excessive Sweating? 2Modern Medical Introduces Opioid Abuse Solution to the Workers' Compensation Industry 2Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2
... 2007 - Arrowhead,Research Corporation (NASDAQ:ARWR) announced today ... the Proceedings of the National Academy of ... to use multiple,systemic dosing with Calando's lead ... proprietary technologies in targeted,polymeric delivery systems and ...
... dermal patch and a direct,current power source ... 20, 2007 /PRNewswire/ -- Dharma Therapeutics,Inc., ("Dharma") ... wholly owned subsidiary of Transcutaneous Technologies, Inc.,("TTI"), ... technology, which administers lidocaine and epinephrine,through the ...
Cached Medicine Technology:Arrowhead Subsidiary, Calando Pharmaceuticals Publishes Study on,Targeted, Systemic Delivery of siRNA 2Arrowhead Subsidiary, Calando Pharmaceuticals Publishes Study on,Targeted, Systemic Delivery of siRNA 3Dharma Therapeutics Shows IDDS Is Effective in Reducing Pain,Associated With Insertion of an Intravenous Catheter in Their Phase,2 Clinical Trial 2Dharma Therapeutics Shows IDDS Is Effective in Reducing Pain,Associated With Insertion of an Intravenous Catheter in Their Phase,2 Clinical Trial 3
... range of prefabricated foot and ankle products ... from ankle instability to foot malalignment. Ossur ... and energy-return technology., ,Age is not ... foot orthoses provide a measure of support, ...
... has a rigid shell with a vacuum liner ... The VacoSplint is a non-weight bearing splint. Once ... should transfer to the STORM walker boot., ... liner from the STORM and insert the vacuum ...
The Active Ankle Trainer model provides medial/lateral support and optimum ankle mobility for chronic and prophylactic use....
... Wee Walker Pediatric Boot is ... pediatric boot that offers superior ... Only two sizes are offered ... sizes will fit left or ...
Medicine Products: